Iron overload remains a significant challenge in the management of β-thalassemia. Early diagnosis and regular monitoring are crucial for preventing organ damage. While chelation therapy is the ...
For those with beta-0 thalassemia, their condition is usually more severe, while beta+ thalassemia tends to be milder. Treatment and Care The main goal of treatment is to reduce painful episodes and ...
Mitapivat, the company’s lead PK activator, was previously granted FDA orphan drug designation for the treatment of PK deficiency, thalassemia, and sickle cell disease. Tebapivat is not approved for ...
Indore (Madhya Pradesh): Patients in Indore are now receiving advanced medical facilities, with the state's first government Super Speciality Hospital introducing haploidentical stem cell transplant ...